We are live on ! Find out more
BDF

Balasa Dinverno & Foltz Portfolio holdings

AUM $1.58B
1-Year Est. Return 17.55%
This Fund
S&P 500
This Quarter Est. Return
-14.12%
1 Year Est. Return
-17.55%
3 Year Est. Return
+23.2%
5 Year Est. Return
+47.16%
10 Year Est. Return
AUM
$1.59B
AUM Growth
+$108M
Cap. Flow
+$377M
Cap. Flow %
23.68%
Top 10 Hldgs %
57.04%
Holding
374
New
30
Increased
160
Reduced
124
Closed
41

Sector Composition

Rank Sector Weight
1 Technology 5.4%
2 Healthcare 3.75%
3 Financials 2.84%
4 Consumer Staples 1.85%
5 Consumer Discretionary 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EBAY icon
151
eBay
EBAY
$47.2B
$765K 0.05%
18,357
-1,401
-7% -$68.3K
UTHR icon
152
United Therapeutics
UTHR
$22.1B
$756K 0.05%
3,207
-442
-12% -$89.9K
DUK icon
153
Duke Energy
DUK
$96.1B
$748K 0.05%
6,981
-174
-2% -$19.1K
TMHC
154
DELISTED
Taylor Morrison
TMHC
$740K 0.05%
31,667
+2,473
+8% +$65.5K
HON icon
155
Honeywell
HON
$72.9B
$734K 0.05%
4,482
+59
+1% +$10.6K
NOC icon
156
Northrop Grumman
NOC
$81.8B
$734K 0.05%
1,533
-51
-3% -$23.4K
RITM icon
157
Rithm Capital
RITM
$5.72B
$724K 0.05%
77,691
+9,345
+14% +$98.1K
IWM icon
158
iShares Russell 2000 ETF
IWM
$81.8B
$717K 0.05%
4,231
+1,115
+36% +$206K
MSCI icon
159
MSCI
MSCI
$40.8B
$714K 0.04%
1,733
NEM icon
160
Newmont
NEM
$124B
$714K 0.04%
11,970
-620
-5% -$43.9K
LBRDK icon
161
Liberty Broadband Class C
LBRDK
$5.32B
$691K 0.04%
5,974
-142
-2% -$17.3K
OXY icon
162
Occidental Petroleum
OXY
$59B
$687K 0.04%
+11,667
New +$717K
UNP icon
163
Union Pacific
UNP
$174B
$682K 0.04%
3,200
+25
+0.8% +$5.69K
TMUS icon
164
T-Mobile US
TMUS
$192B
$672K 0.04%
4,996
+1,029
+26% +$134K
HZNP
165
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$671K 0.04%
8,417
-435
-5% -$41.2K
ODFL icon
166
Old Dominion Freight Line
ODFL
$43.4B
$669K 0.04%
5,220
+18
+0.3% +$2.36K
EFV icon
167
iShares MSCI EAFE Value ETF
EFV
$30B
$668K 0.04%
15,397
+6,628
+76% +$316K
IVE icon
168
iShares S&P 500 Value ETF
IVE
$50B
$661K 0.04%
4,809
EW icon
169
Edwards Lifesciences
EW
$54B
$660K 0.04%
6,944
-57
-0.8% -$5.9K
VICI icon
170
VICI Properties
VICI
$28.6B
$656K 0.04%
22,024
+9,394
+74% +$277K
PCH
171
DELISTED
PotlatchDeltic
PCH
$655K 0.04%
14,819
+8,939
+152% +$461K
VBR icon
172
Vanguard Morningstar Small-Cap Value ETF
VBR
$38B
$639K 0.04%
4,267
+95
+2% +$15.6K
CNXC icon
173
Concentrix
CNXC
$1.57B
$633K 0.04%
4,665
-237
-5% -$35.7K
VTV icon
174
Vanguard Morningstar Value ETF
VTV
$192B
$614K 0.04%
4,653
+5
+0.1% +$705
RHI icon
175
Robert Half
RHI
$4.31B
$609K 0.04%
8,138
-2,267
-22% -$215K

Similar funds

Balasa Dinverno & Foltz's Q2 2022 Portfolio in Review

As of Q2 2022, Balasa Dinverno & Foltz held 374 positions worth $1.59B, up 7.3% from $1.48B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Balasa Dinverno & Foltz deployed $377M of net new capital in Q2 2022, opening 30 new positions and adding to 160 existing holdings. Its largest new stake was Dimensional US Marketwide Value ETF: 7,658,446 shares worth $242M.

By sector, the portfolio is most concentrated in Technology at 5.4% of assets, down from 7.2% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Dimensional US Targeted Value ETF, an estimated $7.19M trimmed.

  • Balasa Dinverno & Foltz's largest Q2 2022 buy was Dimensional US Marketwide Value ETF: 7,658,446 shares worth $242M.
  • Balasa Dinverno & Foltz added most to Dimensional US Small Cap Value ETF in Q2 2022, an estimated $12.3M increase.
  • Balasa Dinverno & Foltz's biggest Q2 2022 reduction was Dimensional US Targeted Value ETF, cutting an estimated $7.19M.
  • Balasa Dinverno & Foltz fully exited Cerner Corp in Q2 2022, selling an estimated $1.23M.
  • Balasa Dinverno & Foltz's ten largest holdings make up 57% of its $1.59B portfolio in Q2 2022.
  • Balasa Dinverno & Foltz opened 30 new positions and closed 41 in Q2 2022.
  • Balasa Dinverno & Foltz's portfolio value rose 7.3% quarter-over-quarter to $1.59B.

Based on Balasa Dinverno & Foltz's 13F filing for Q2 2022, filed 9 Aug 2022.